Procurement was once seen as just a link in the chain of business operations. It was the process by which operators secured ...

I want to empower Investors, to make as much money, from both income and capital appreciation, with as little risk as possible, through my coverage of dividend, growth, and value companies. This broad ...

Too often, cybersecurity teams find themselves in a reactive mode, limiting their ability to think strategically about cyber risk management and resource allocation. However, applying best practices ...

Unplanned supply chain incidents deliver sizeable impacts on businesses and the global economy. Thus, businesses should be aware of these possible risks and take robust steps to protect against them.

The era of historically low interest rates in the U.S. is over. Amidst aggressive moves from the Federal Reserve to curb inflation, businesses are facing a volatile rate environment for the first time ...

“Without a solid risk-management foundation, AI trading is nothing more than high-speed speculation,” Luka Lah states.

This paper addresses strategic risk management as an essential discipline for the sustainability of large corporations in an environment marked by increasing uncertainties and rapid transformations.

Recently we talked about how networks played a critical role in both the crash and recovery of JetBlue after its Valentine’s Day debacle. That’s a specific case of the broader question, “What’s the ...

While boards want ESG accountability, vague language in investment policy statements creates confusion and risk rather than clarity.

Forbes contributors publish independent expert analyses and insights. Tony Bradley covers the intersection of tech and entertainment. NinjaOne announced an integration with SentinelOne earlier this ...

It is no secret that the National Association of Realtors (NAR) has faced its fair share of legal challenges over the past few years. From the commission lawsuits, to an investigation by the ...

A panel discussion covers considerations within REMS programs aimed at minimizing risks associated with bispecific therapy. NOTE: Not all FDA-approved bispecific antibodies are associated with a REMS ...